| dc.contributor.author | Rojas-Moreno, Christian | eng |
| dc.date.issued | 2019-01 | eng |
| dc.description | Includes summary of warnings from the Food and Drug Administration (FDA) over the years. | eng |
| dc.description.abstract | "Fluoroquinolones can be the drug of choice in several clinical situations due to their antibacterial spectrum, good tissue penetration, and excellent oral bioavailability. However, side effects, drug interactions and the risk of C. difficile infections are making us think twice before prescribing fluoroquinolones." | eng |
| dc.description.bibref | | eng |
| dc.description.statementofresponsibility | Christian Rojas-Moreno (Division of Infectious Diseases, Department of Medicine, University of Missouri) | eng |
| dc.format.extent | 1 page | eng |
| dc.identifier.citation | Am J Hosp Med 2019 Jan;3(1):2019.004 https://doi.org/10.24150/ajhm/2019.004 | eng |
| dc.identifier.uri | https://hdl.handle.net/10355/82683 | |
| dc.identifier.uri | https://doi.org/10.24150/ajhm/2019.004 | eng |
| dc.language | English | eng |
| dc.publisher | University of Missouri, Department of Medicine, Division of Hospital Medicine | eng |
| dc.relation.ispartof | American journal of hospital medicine, volume 3, issue 1 (2019 January-March) | eng |
| dc.relation.ispartofseries | ID Corner | eng |
| dc.rights | OpenAccess. | eng |
| dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License. | |
| dc.source | Harvested from the American Journal of Hospital Medicine website (https://medicine.missouri.edu/departments/medicine/divisions/hospital-medicine/american-journal-of-hospital-medicine) in 2021. | eng |
| dc.subject | Fluoroquinolones | eng |
| dc.subject | Drug Risks | eng |
| dc.subject | Label Warnings | eng |
| dc.title | Fluoroquinolones : more and more warnings | eng |
| dc.type | Article | eng |
![[PDF]](/xmlui/themes/Mirage2//images/mimes/pdf.png "PDF file"){kind=small}